Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1NET 1Endocrine 1

Conditions

Respiratory Insufficiency 1Radiation Pneumonitis 1Neuroendocrine Tumors 1Lung Neoplasms 1Lung Diseases 1Abnormalities, Radiation-Induced 1

Interventions

pembrolizumab 1282Specimen Handling 927Carboplatin 836Magnetic Resonance Spectroscopy 834Cyclophosphamide 807Cisplatin 735Nivolumab 680Paclitaxel 635Radiotherapy 617Gemcitabine 580Biopsy 559Bevacizumab 485Dexamethasone 444fludarabine 410Docetaxel 385venetoclax 372Oxaliplatin 367Capecitabine 361Fluorouracil 357atezolizumab 350durvalumab 340Rituximab 335Drug Therapy 333Radiosurgery 321Doxorubicin 319Blood Specimen Collection 317Standard of Care 311Pemetrexed 307Ipilimumab 303Radiation 287

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Tomography, Emission-Computed, Single-Photon × 1 year × Clear all
NCT06122610 2026-05-15

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

University of Wisconsin, Madison

Phase 1 Recruiting
10 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT04676828 2026-02-24

ASPECT

University of Aarhus

Phase NA Recruiting
90 enrolled
Thoracic

Abnormalities, Radiation-Induced, Lung Diseases, Lung Neoplasms, Respiratory Insufficiency, Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡